Ge Healthcare Technologies INC Form 4 insider transactions

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro disposed of 948 shares of common stock to cover tax obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc. CEO Peter J. Arduini reported a scheduled disposition of 3,210 common shares on February 1, 2026, to cover tax withholding obligations from restricted stock unit vesting.

GE HealthCare's CEO of Imaging, Roland Rott, exercised employee stock options and adjusted common stock holdings to cover tax obligations.

GE HealthCare Technologies' Chief Enterprise Operations Officer, Kenneth R. Stacherski, disposed of 892 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc.'s Chief People Officer, Adam Y. Holton, disposed of 464 common shares to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc.'s Chief Technology Officer, Taha Kass-Hout, disposed of 2,897 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc. CEO of AVS, Philip Rackliffe, disposed of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., disposed of shares to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare's General Counsel, Frank R. Jimenez, disposed of common stock to cover tax liabilities related to restricted stock unit vesting.

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro reported the disposition of shares to cover tax obligations from restricted stock unit vesting.

GE HealthCare Technologies Inc. President and CEO, Peter J. Arduini, disposed of 11,346 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc. Chief Enterprise Operations Officer Kenneth R. Stacherski received an award of 10,217 restricted stock units.

GE HealthCare Technologies Inc.'s Chief Financial Officer, James Saccaro, disposed of 9,712 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

GE HealthCare Technologies Inc. announced that Director Risa J. Lavizzo-Mourey was granted 3,092 restricted stock units as part of her compensation, aligning her interests with shareholders.

GE HealthCare Technologies Inc. Director Catherine A. Lesjak was awarded 3,092 restricted stock units, increasing her beneficial ownership to 9,116 shares.

GE HealthCare Technologies Inc. Director Lloyd Howell Jr. was granted 3,092 restricted stock units, increasing his beneficial ownership to 9,116 shares.

GE HealthCare Technologies Inc. Director Anne T. Madden reported the acquisition of restricted stock units and deferred stock units as part of her compensation, increasing her beneficial ownership to 13,611 shares.

GE HealthCare Technologies Inc. Director Tomislav Mihaljevic was awarded 3,092 restricted stock units, increasing his beneficial ownership to 9,116 shares.

GE HealthCare Technologies Inc. Director Rodney F. Hochman acquired 4,848 shares of common stock through restricted and deferred stock unit awards on May 28, 2025, increasing his total beneficial ownership to 13,611 shares.

GE HealthCare Technologies Inc. Director Phoebe L. Yang received an award of 3,092 restricted stock units, increasing her total beneficial ownership to 9,116 shares of common stock.

GE HealthCare Technologies Inc. Director William J. Stromberg has increased his beneficial ownership in the company by acquiring 5,129 shares through restricted stock units and deferred stock units as part of his compensation.

GE HealthCare Technologies Inc. Director H. Lawrence Culp Jr. reported the acquisition of 6,675 shares of common stock on May 28, 2025, through restricted stock unit and deferred stock unit awards, increasing his direct and indirect beneficial ownership.

Jeannette Bankes, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the acquisition of stock options and restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., files an amended SEC Form 4 to correct the number of shares withheld for tax obligations related to vesting restricted stock units.

George A. Newcomb, Chief Accounting Officer of GE HealthCare Technologies Inc., reports acquisition and disposal of company stock and stock options.

Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., reports the acquisition and disposal of company stock and stock options.

CEO Kevin O'Neill reports acquisition and disposal of GE HealthCare Technologies Inc. stock and stock options.

Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., reports acquisition of shares and stock options.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., reports acquisition of shares and stock options.

Chief Financial Officer James Saccaro of GE HealthCare Technologies Inc. reports the acquisition of restricted stock units and employee stock options.